@TexasTech Tag

11 Sep FDA Approves Tonmya: First-in-Class, Non-Opioid Analgesic for Fibromyalgia

[caption id="attachment_70643" align="alignleft" width="200"] Dr. Jain[/caption] MedicalResearch.com Interview with: Rakesh Jain, MD, MPH Clinical Professor at the Department of Psychiatry Texas Tech University School of Medicine- Permian Basin Midland, Texas MedicalResearch.com: Would you briefly explain the condition of fibromyalgia?  Whom does it primarily affect and what are the symptoms? Response:  Fibromyalgia is the prototypical example of a type of pain called nociplastic pain, or pain that comes from altered pain processing in the central nervous system. It is mainly characterized by widespread pain, non-restorative sleep, fatigue and cognitive impairment (brain fog). Over 10 million adults in the United States are affected by this disease, most of whom are women.